Speaker illustration

Doctor Salva Reverentia Yurista

Cleveland Clinic Hospital, Cleveland (United States of America)

Member of:

European Society of Cardiology
Heart Failure Association

Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with heart failure after myocardial infarction

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Moderated Poster Session - Basic Science


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb